MOUNTAIN VIEW, Calif. -- DNAnexus, Inc., the leading cloud-based biomedical and data management platform for healthcare and life sciences, today announced the appointment of Asha S. Collins, PhD, to General Manager, Biobanks. Dr. Collins will be responsible for managing the UK Biobank project and supporting the company’s diverse global health research community. She will report [...]

Fremont, CA -- Alamar Biosciences, Inc., a precision proteomics company that brings both ultra-high sensitivity and massively parallel scale to proteomic analysis, announced today that it has closed its $80 million Series B financing round, bringing its total funding to $110 million. The Series B financing round was led by Sherpa Healthcare Partners and included [...]

Thermo Scientific Vanquish Neo UHPLC System and Thermo Scientific PepMap Neo Columns enable consistent, high-quality results in high-sensitivity LC-MS workflows GERMERING, Germany -- Principal investigators, laboratories, and proteomics researchers in academia, biopharma and contract research organizations can now benefit from an all-in-one nano-, capillary- and micro-flow liquid chromatography (LC) system. Designed for high sensitivity LC-mass spectrometry (LC-MS) applications, [...]

SAN DIEGO and SHANGHAI, China -- Bionano Genomics, Inc. (Nasdaq: BNGO) announced today that NuProbe Global, a global molecular diagnostics company based in Shanghai, China and Houston, Texas, has adopted Bionano’s Saphyr system for optical genome mapping (OGM) to integrate their Quantitative Amplicon Sequencing (QASeq) and Blocker Displacement Amplification (BDA) technologies for research and product [...]

Researcher recognized for influential work on genome editing and CRISPR applications SANTA CLARA, Calif. --  Agilent Technologies Inc. (NYSE: A) today announced Dr. David R. Liu has been selected to receive a prestigious Agilent Thought Leader Award. A prominent researcher in the field of genome editing, Dr. Liu is Professor and Director of the Merkin Institute of Transformative Technologies [...]

The IGX Platform empowers researchers to accurately predict exposed liabilities for thousands of sequences at the same time using high-throughput structural modeling ‘s-Hertogenbosch, The Netherlands – Life Science Newswire – ENPICOM, an innovative bioinformatics software company, announced today at the Biologics UK conference new IGX Platform capabilities to accurately annotate exposed liabilities, perform structural modeling [...]

SAN DIEGO -- Illumina, Inc. (NASDAQ: ILMN) and Merck (known as MSD outside the United States and Canada) today announced a partnership to develop and commercialize tests that identify genetic mutations used in the assessment of homologous recombination deficiency (HRD). Patients whose tumors are HRD-positive may be eligible for targeted treatment by a class of [...]

SCOTTSDALE, Ariz. -- INanoBio, a startup developing early stage disease diagnostics by combining semiconductor nanotechnology with biotechnology and machine learning, today announced it has successfully fabricated initial prototypes of its novel Field Effect Nanopore Transistor (FENT) device. FENT is INanoBio’s proprietary technology, a revolutionary device that combines CMOS transistor technology with solid state nanopores for [...]

Burlington, MA -- RedShift BioAnalytics (RedShiftBio), a company providing next-generation platform technology enabling measurements of previously undetectable structure changes in biomolecules, announced the appointment of Amol Chaubal to its Board of Directors. Chaubal is Chief Financial Officer at Waters Corporation, the world’s leading specialty measurement company, which has pioneered chromatography, mass spectrometry, and thermal analysis innovations [...]

Company plans to expand research and development and scale commercial organization to support global customer base  BOSTON, MA — Emulate, Inc., a leading provider of next generation in vitro models, today announced the close of an $82 million Series E financing round led by existing investor Northpond Ventures with additional participation from Perceptive Advisors. With this investment, Emulate has raised nearly $225 million to date. “This [...]